Abstract
The heterogeneity and plasticity of T lymphocytes is critical for determining immune response outcomes. Functional regulatory T (Treg) cells are commonly characterized by stable FOXP3 expression and have reported to exhibit heterogeneous phenotypes under inflammatory conditions. However, the interplay between inflammation and Treg cell suppressive activity still remains elusive. Here, we utilized single-cell RNA sequencing to investigate how human Treg cells respond to the pro-inflammatory cytokine interleukin-6 (IL-6). We observed that Treg cells divided into two subpopulations after IL-6 stimulation. TIGIT− unstable Treg cells lost FOXP3 expression and gained an effector-like T cell phenotype, whereas TIGIT+ Treg cells retained robust suppressive function. Single cell transcriptome analysis revealed a spectrum of cellular states of IL-6-stimulated Treg cells and how cytochrome P450 family 1 subfamily A member 1 (CYP1A1) is a crucial regulator of Treg cell suppressive capability and stability. CYP1A1-deficient human Treg cells developed a Th17-like phenotype after IL-6 stimulation. Our findings implicate CYP1A1 as a previously unidentified regulator of Treg cells that may have target potential for clinical application for biotherapies.
Highlights
CD4+CD25+ regulatory T (Treg) cells are essential for immune homeostasis
The immunosuppressive function of partially stable Treg cells can be disarmed allowing for adoption of effector functions; stable Treg cells are sensitive to inflammatory signals and infiltrate into inflamed tissue to prevent excessive inflammation in the presence of IL-6
We found Treg cells heterogeneity with similarity from Treg derived from cord blood (Fig. S1 online)
Summary
CD4+CD25+ regulatory T (Treg) cells are essential for immune homeostasis. Transcription factor forkhead-box-P3 (FOXP3) is specific expressed in Treg cells and play a crucial role in maintaining the expression of Treg immunosuppressive signature genes [1]. FOXP3 controls the expression of a range of immune modulatory genes, which distinguishes Treg cells from CD4+FOXP3À conventional T cells [2,3]. Been depicted by recent studies that immunosuppressive capability of Treg cells can be depressed under specific environmental signals while inflammatory effector gene expression is induced [7,8,9,10,11]. TIGIT as a co-inhibitory molecule, is highly expressed in Treg cells and directly inhibits T cell activation and proliferation. TIGIT high expressed Treg cells may define an activated functionally Treg cell subset [14].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.